- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01936467
Comparison of Two Needle Aspiration Techniques for Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) in Solid Pancreatic Lesions
Comparison of Two Needle Aspiration Techniques for Endoscopic Ultrasound-guided
The aim of this study is to compare Endoscopic Ultrasound and Fine Needle Aspirate with a standard 22-gauge needle using either "standard-suction" or "capillary suction" methods for solid pancreatic lesions. Investigators hope to discover the best technique for obtaining diagnostic material when patients with a pancreatic mass undergo endoscopic ultrasound and fine needle aspirate procedure.
There are currently several techniques for obtaining tissue during endoscopic ultrasound and fine needle aspirate. The procedure will be performed by either the capillary suction technique or no suction technique.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Johns Hopkins Hospital
-
Columbia, Maryland, United States, 21044
- Howard County General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- In-patients and out-patients between the age of 18years and 90 years with pancreatic masses presenting for EUS-FNA
Exclusion Criteria:
- Uncorrectable coagulopathy (INR > 1.5)
- Uncorrectable thrombocytopenia (platelet < 50,000)
- Uncooperative patients
- Pregnant women (women of childbearing age will undergo urine pregnancy testing, which is routine for all endoscopic procedures)
- Refusal to consent form
- Cystic lesions
- Inaccessible lesions to EUS
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Standard suction
These are patients who will have endoscopic ultrasound-guided fine needle aspiration using the standard suction FNA technique: 15 to-and-fro movements within the lesion will be performed with use of 10cc suction syringe.
|
Standard suction Endoscopic Ultrasound- Fine Needle Aspiration (EUS-FNA) technique using the 22-gauge (Expect needle; Boston Scientific) needle: 15 to-and-fro movements within the lesion will be performed with use of 10cc suction syringe.
|
|
Experimental: Capillary suction
These are patients who will have endoscopic ultrasound-guided fine needle aspiration using the capillary suction FNA technique: 15 to-and-fro movements within the lesion will be performed with simultaneous minimal negative pressure provided by pulling the needle stylet slowly and continuously.
|
Capillary suction Endoscopic Ultrasound- Fine Needle Aspiration (EUS-FNA) technique using the 22-gauge (Expect needle; Boston Scientific) needle: 15 to-and-fro movements within the lesion will be performed with simultaneous minimal negative pressure provided by pulling the needle stylet slowly and continuously
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic Yield of Capillary Technique
Time Frame: up to 6 months
|
Diagnostic yield is defined as percentage of specimens in which diagnostic material is obtained.
|
up to 6 months
|
|
Diagnostic Yield of Standard Technique
Time Frame: up to 6 months
|
Diagnostic yield is defined as percentage of specimens in which diagnostic material is obtained.
|
up to 6 months
|
|
Sensitivity of EUS-FNA With Capillary Technique
Time Frame: 6 months
|
Sensitivity of the EUS-FNA with Capillary technique
|
6 months
|
|
Sensitivity of EUS-FNA With StandardTechnique
Time Frame: 6 months
|
Sensitivity of the EUS-FNA with Capillary technique
|
6 months
|
|
Sensitivity of EUS-FNA
Time Frame: 6 months
|
Comparison of EUS-FNA sensitivity using Capillary technique versus Standard technique for pancreatic solid lesions
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
First Pass Diagnostic Rate
Time Frame: immediate
|
The rate of aquiring diagnostic pancreatic mass tissue with first FNA pass
|
immediate
|
|
Acquisition of Core Tissue
Time Frame: immediate
|
The rate of acquiring core tissue of the pancreatic mass through EUS-FNA
|
immediate
|
|
Diagnostic Accuracy of EUS-FNA
Time Frame: 6 months
|
The proportion of subjects without the disease with negative EUS-FNA in total of subjects without the disease
|
6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Mouen A Khashab, MD, Johns Hopkins Univeristy
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- NA_00079301
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pancreatic Solid Lesions
-
National Taiwan University HospitalRecruiting
-
The University of Texas Health Science Center,...Recruiting
-
National Taiwan University HospitalCompleted
-
The Third Xiangya Hospital of Central South UniversityCompletedPancreatic Solid LesionsChina
-
ARNAS Civico Di Cristina Benfratelli HospitalCompletedPancreatic Solid LesionsItaly
-
University of Alabama at BirminghamCompleted
-
Nanfang Hospital of Southern Medical UniversityShenzhen People's Hospital; Second Affiliated Hospital of Guangzhou Medical...Not yet recruitingSolid Pancreatic Lesions | EUS-FNB
-
Changhai HospitalSun Yat-sen University; Ruijin Hospital; Wuhan Union Hospital, China; The Third...RecruitingAI Assist in the Diagnosis of Pancreatic Solid LesionsChina
-
Amplified Sciences IncRecruitingPancreatic Cystic LesionsUnited States
-
Boston Scientific CorporationCompletedPancreatic Cystic LesionsUnited States, China, India
Clinical Trials on Standard technique EUS-FNA
-
University Hospital, GhentCompleted
-
The Third Xiangya Hospital of Central South UniversityUnknownSolid Pancreatic MassesChina
-
Asan Medical CenterCompletedPancreatic MassesKorea, Republic of
-
Shyam VaradarajuluCompletedPancreatic TumorsUnited States
-
University of Colorado, DenverUS EndoscopyRecruitingPancreatic CystUnited States
-
Bin ChengCompleted
-
National Cancer Center, KoreaCompleted
-
American Society for Gastrointestinal EndoscopyMidwest Biomedical Research FoundationUnknownMediastinal or Intra-abdominal Lymphadenopathy, | Pancreatic Masses, | Left Adrenal Masses, | Gastrointestinal Submucosal Lesions, and | Liver MassesUnited States
-
AdventHealthUniversity of Alabama at BirminghamCompletedPancreatic CancerUnited States
-
Region SkaneTerminatedGastrointestinal NeoplasmsSweden